ArticleNPJ precision oncology2025

A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancer.

Narayanan Sadagopan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.